We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sensitive Tool Implicates New Rhinovirus in Pediatric Respiratory Infections

By Biotechdaily staff writers
Posted on 28 Nov 2007
A rapid, sensitive, and inexpensive diagnostic tool implicated a new human rhinovirus (HRV) as the cause of severe pediatric respiratory tract infections in Europe.

Scientists used the new tool, which is called MassTag polymerase chain reaction (PCR), to investigate 97 samples, collected over a three-year period, from children with hospital-admitted, acute respiratory illness where no pathogen had been identified by routine laboratory testing. More...
HRVs were the most frequent viruses detected in the sample set, representing 75% of the identified viruses.

Human rhinoviruses are frequent causes of respiratory illness worldwide. Although they are most commonly associated with self-limited upper respiratory tract disease, lower respiratory tract infections related to HRVs are being increasingly reported in infants, elderly persons, and immunocompromised patients. HRVs are also implicated in exacerbations of asthma, chronic bronchitis, and acute bronchiolitis.

To detect pathogens, MassTag PCR uses small molecular tags to detect up to 30 different pathogens simultaneously in one test. Genetic material from a throat swab or other sample is extracted and then mixed with PCR primers--short pieces of DNA that recognize specific nucleic acid sequences within the genomes of the target viruses or bacteria. If a throat swab contains pathogens with nucleic acid sequences that match those of the primers, then the primers will copy the target DNA several million times. Likewise, the molecular tags, different in mass for each of the primers, are also amplified, making them easily detectable by mass spectrometry, a technology that identifies molecules based on their masses.

"The results of the study confirm our earlier findings in New York, namely, that these viruses represent a clinically significant but previously unappreciated species within the entero-/rhinoviruses, one of the longest known and most intensely studied virus groups,” stated Thomas Briese, Ph.D., associate professor of clinical epidemiology at Columbia University Mailman School of Public Health's Center for Infection and Immunity (New York, NY, USA) who coordinated the study. "We urgently need drugs and vaccines to address the challenges they pose to child health.”

The study appeared in the November 2007 online edition of the Journal of Infectious Diseases.


Related Links:
Columbia University Mailman School of Public Health

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.